FIMM alumna Mari Niemi began her academic career in neuroscience and committed her postdoctoral research to COVID-19 host genetics before taking a career step into applied data science in industry.

Ieva Rauluševičiūtė is a Doctoral Research Fellow in the Mathelier group at NCMM. She recently spent one month with the groups of Dr Judith Zaugg and Dr Arnaud Krebs at the EMBL Headquarters in Heidelberg, Germany.

DANDRITE Team Leader Gilles Vanwalleghem studies communication between the gut and the brain, and how disruption of such can happen and affect immune function and behavior.

International research consortia have analyzed common and rare DNA variants in hundreds of thousands of people, revealing clearest genetic signals yet for schizophrenia risk.

NCMM is delighted to announce that Dr Biswajyoti Sahu has been recruited as a new group leader for Precision Medicine. Dr Sahu will join us in September 2022 from the University of Helsinki, Finland.

Even several months after COVID-19, one is still at an increased risk of blood clot and bleeding. In the worst case, a blood clot can be fatal; however, it can often be treated or prevented. These are the findings of a study from Umeå University, Sweden, where researchers analyzed all COVID-19 cases in Sweden from the start of the pandemic until May last year.

NCMM is delighted to announce that Dr. Charlotte Boccara has been recruited as a new group leader under the Centre’s precision medicine umbrella. Dr. Boccara joins NCMM in April 2022 to establish and head the Systems Neuroscience & Sleep group, aiming to decode sleep function in healthy development.